Gene expression profiling in postmortem prefrontal cortex of major depressive disorder

Area of Science:

• Neuroscience
• Molecular Psychiatry
• Genetics

Background:

• Investigating molecular mechanisms of major depressive disorder (MDD) is challenging due to brain tissue complexity and gene expression profiling sensitivity limitations.
• Previous studies faced difficulties in accurately profiling gene expression in brain tissue for MDD research.

Purpose of the Study:

• To identify specific molecular alterations in the dorsolateral prefrontal cortex (DLPFC) of individuals with MDD.
• To overcome limitations in gene expression profiling sensitivity and brain tissue complexity in MDD research.

Main Methods:

• Utilized discrete microdissections of postmortem dorsolateral prefrontal cortex (DLPFC, area 9).
• Employed sensitive oligonucleotide (60mer) microarray hybridization without RNA amplification.
• Applied mixed-effects statistical methods to control for medication effects in subjects.

Main Results:

• A comprehensive profile of dysregulated genes in the DLPFC of MDD subjects was identified.
• Stresscopin (a neuropeptide) and Forkhead box D3 (FOXD3, a transcription factor) were among the most significantly upregulated genes.
• Cell-based analysis confirmed increased levels of stresscopin and FOXD3 in DLPFC neurons of MDD patients.

Conclusions:

• Abnormal gene expression patterns exist in specific brain regions of individuals with MDD.
• Stresscopin and FOXD3 are implicated in the molecular pathology of major depressive disorder.
• These findings advance the understanding of the complex molecular alterations contributing to MDD.